Smiths, MediPurpose expand deal for safety lancets distribution
This article was originally published in Clinica
For an undisclosed fee, UK medical device group Smiths Medical and US healthcare solutions company MediPurpose have expanded an existing distribution deal for the latter’s safety lancets to encompass the whole European market. The exclusive partnership follows an earlier agreement, struck in January this year, which saw London based Smiths distribute the SurgiLance lancets solely in France. According to MediPurpose (Norcross, Georgia), the SurgiLance safety lancets are “one of the most convenient and safe lancets available in the market for micro blood sampling”, as they are colour-coded for easy-recognition and safe, and the needle is safely concealed before and after use.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals